191 related articles for article (PubMed ID: 33634849)
21. Intrauterine device use and endometrial cancer risk.
Sturgeon SR; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR
Int J Epidemiol; 1997 Jun; 26(3):496-500. PubMed ID: 9222773
[TBL] [Abstract][Full Text] [Related]
22. Design of the Association of Uterine Perforation and Expulsion of Intrauterine Device study: a multisite retrospective cohort study.
Anthony MS; Reed SD; Armstrong MA; Getahun D; Gatz JL; Saltus CW; Zhou X; Schoendorf J; Postlethwaite DA; Raine-Bennett T; Fassett MJ; Peipert JF; Ritchey ME; Ichikawa LE; Lynen R; Alabaster AL; Merchant M; Chiu VY; Shi JM; Xie F; Hui SL; Wang J; Hunter S; Bartsch J; Frenz AK; Chillemi G; Im TM; Takhar HS; Asiimwe A
Am J Obstet Gynecol; 2021 Jun; 224(6):599.e1-599.e18. PubMed ID: 33460585
[TBL] [Abstract][Full Text] [Related]
23. Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin.
Kotsopoulos J; Terry KL; Poole EM; Rosner B; Murphy MA; Hecht JL; Crum CP; Missmer SA; Cramer DW; Tworoger SS
Int J Cancer; 2013 Aug; 133(3):730-9. PubMed ID: 23364849
[TBL] [Abstract][Full Text] [Related]
24. Associations of early life and adulthood adiposity with risk of epithelial ovarian cancer.
Huang T; Tworoger SS; Willett WC; Stampfer MJ; Rosner BA
Ann Oncol; 2019 Feb; 30(2):303-309. PubMed ID: 30576422
[TBL] [Abstract][Full Text] [Related]
25. Early life exposure to tobacco smoke and ovarian cancer risk in adulthood.
Wang T; Townsend MK; Vinci C; Jake-Schoffman DE; Tworoger SS
Int J Epidemiol; 2021 Jul; 50(3):965-974. PubMed ID: 33647961
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
[TBL] [Abstract][Full Text] [Related]
27. Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.
O'Brien KM; Tworoger SS; Harris HR; Anderson GL; Weinberg CR; Trabert B; Kaunitz AM; D'Aloisio AA; Sandler DP; Wentzensen N
JAMA; 2020 Jan; 323(1):49-59. PubMed ID: 31910280
[TBL] [Abstract][Full Text] [Related]
28. Obesity and the risk of systemic lupus erythematosus among women in the Nurses' Health Studies.
Tedeschi SK; Barbhaiya M; Malspeis S; Lu B; Sparks JA; Karlson EW; Willett W; Costenbader KH
Semin Arthritis Rheum; 2017 Dec; 47(3):376-383. PubMed ID: 28688713
[TBL] [Abstract][Full Text] [Related]
29. Invasive cervical cancer and intrauterine device use.
Lassise DL; Savitz DA; Hamman RF; Barón AE; Brinton LA; Levines RS
Int J Epidemiol; 1991 Dec; 20(4):865-70. PubMed ID: 1800424
[TBL] [Abstract][Full Text] [Related]
30. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies.
Rice MS; Hankinson SE; Tworoger SS
Fertil Steril; 2014 Jul; 102(1):192-198.e3. PubMed ID: 24825424
[TBL] [Abstract][Full Text] [Related]
31. Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk.
Sasamoto N; Babic A; Vitonis AF; Titus L; Cramer DW; Trabert B; Tworoger SS; Terry KL
Cancer Prev Res (Phila); 2021 Aug; 14(8):795-802. PubMed ID: 34244153
[TBL] [Abstract][Full Text] [Related]
32. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.
Castellsagué X; Díaz M; Vaccarella S; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Meijer CJ; Bosch FX
Lancet Oncol; 2011 Oct; 12(11):1023-31. PubMed ID: 21917519
[TBL] [Abstract][Full Text] [Related]
33. Intrauterine device use and the risk of pre-eclampsia: a case-control study.
Parker SE; Jick SS; Werler MM
BJOG; 2016 Apr; 123(5):788-95. PubMed ID: 25854682
[TBL] [Abstract][Full Text] [Related]
34. Early life physical activity and risk of ovarian cancer in adulthood.
Wang T; Jake-Schoffman DE; Townsend MK; Vinci C; Willett WC; Tworoger SS
Int J Cancer; 2021 Dec; 149(12):2045-2051. PubMed ID: 34398976
[TBL] [Abstract][Full Text] [Related]
35. Estrogen Receptor-β Expression of Ovarian Tumors and Its Association with Ovarian Cancer Risk Factors.
Shafrir AL; Babic A; Gates Kuliszewski M; Rice MS; Townsend MK; Hecht JL; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2211-2219. PubMed ID: 32856599
[TBL] [Abstract][Full Text] [Related]
36. Current use of an intrauterine device and risk of tubal pregnancy.
Rossing MA; Daling JR; Voigt LF; Stergachis AS; Weiss NS
Epidemiology; 1993 May; 4(3):252-8. PubMed ID: 8512989
[TBL] [Abstract][Full Text] [Related]
37. Intrauterine device use among women with ovarian cancer: a systematic review.
Zapata LB; Whiteman MK; Marchbanks PA; Curtis KM
Contraception; 2010 Jul; 82(1):38-40. PubMed ID: 20682141
[TBL] [Abstract][Full Text] [Related]
38. Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk.
Lurie G; Terry KL; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Palmieri RT; Cramer DW; Goodman MT
Cancer Causes Control; 2010 Oct; 21(10):1731-41. PubMed ID: 20559705
[TBL] [Abstract][Full Text] [Related]
39. Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts.
Pinheiro SP; Tworoger SS; Cramer DW; Rosner BA; Hankinson SE
Am J Epidemiol; 2009 Jun; 169(11):1378-87. PubMed ID: 19342401
[TBL] [Abstract][Full Text] [Related]
40. Surrogates of long-term vitamin d exposure and ovarian cancer risk in two prospective cohort studies.
Prescott J; Bertrand KA; Poole EM; Rosner BA; Tworoger SS
Cancers (Basel); 2013 Nov; 5(4):1577-600. PubMed ID: 24351671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
